Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IDX20963
IDX20963
Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex
Yahoo/24-7 Wallstreet
Sat, 11/2/13 - 11:27 am
IDX20963
hepatitis C
hepatitis
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
This Week in Biotech
Motley Fool
Sun, 06/23/13 - 11:11 am
Nektar
NKTR-181
pain management
Novartis
serelaxin
Idenix
IDX20963
hepatitis C
ViroPharma
JNJ
Aragon
ARN-509
prostage cancer
Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again
Motley Fool
Sat, 06/22/13 - 09:46 am
Idenix
IDX20963
hepatitis C
Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials
Yahoo/AP
Fri, 06/21/13 - 09:16 am
Idenix
FDA
hepatitis C
IDX20963